Abstract:The accumulation of amyloid plaques and increased brain redox burdens are neuropathological hallmarks of Alzheimer's disease. Altered metabolism of essential biometals is another feature of Alzheimer's, with amyloid plaques representing sites of disturbed metal homeostasis. Despite these observations, metal-targeting disease treatments have not been therapeutically effective to date. A better understanding of amyloid plaque composition and the role of the metals associated with them is critical. To establish this knowledge, the ability to resolve chemical variations at nanometer length scales relevant to biology is essential. Here, we present a methodology for the label-free, nanoscale chemical characterization of amyloid plaques within human Alzheimer's disease tissue using synchrotron X-ray spectromicroscopy. Our approach exploits a C-H carbon absorption feature, consistent with the presence of lipids, to visualize amyloid plaques selectively against the tissue background, allowing chemical analysis to be performed without the addition of amyloid dyes that alter the native sample chemistry. Using this approach, we show that amyloid plaques contain elevated levels of calcium, carbonates, and iron compared to the surrounding brain tissue. Chemical analysis of iron within plaques revealed the presence of chemically reduced, low-oxidation-state phases, including ferromagnetic metallic iron. The zero-oxidation state of ferromagnetic iron determines its high chemical reactivity and so may contribute to the redox burden in the Alzheimer's brain and thus drive neurodegeneration. Ferromagnetic metallic iron has no established physiological function in the brain and may represent a target for therapies designed to lower redox burdens in Alzheimer's disease. Additionally, ferromagnetic metallic iron has magnetic properties that are distinct from the iron oxide forms predominant in tissue, which might be exploitable for the in vivo detection of amyloid pathologies using magnetically sensitive imaging. We anticipate that this label-free X-ray imaging approach will provide further insights into the chemical composition of amyloid plaques, facilitating better understanding of how plaques influence the course of Alzheimer's disease.

Re-evaluating the nuclear staining on pathological sections in Alzheimer’s disease

Aβ-Aggregation-Generated Blue Autofluorescence Illuminates Senile Plaques As Well As Complex Blood and Vascular Pathologies in Alzheimer’s Disease

Aβ-Aggregation-Generated Blue Autofluorescence Illuminates Senile Plaques as well as Complex Blood and Vascular Pathologies in Alzheimer's Disease

Senile Plaques in Alzheimer’s Disease Arise from Aβ and Cathepsin D-enriched Amyloidogenic Mixtures out of Intravascular Hemolysis and Charcot-Bouchard Aneurysm-Related Vascular Degeneration

C1q–calreticulin Induced Oxidative Neurotoxicity: Relevance for the Neuropathogenesis of Alzheimer's Disease

Senile Plaques in Alzheimer's Disease Arise from Aβ‐ and Cathepsin D‐enriched Mixtures Leaking out During Intravascular Haemolysis and Microaneurysm Rupture

High Contrast and Resolution Labeling of Amyloid Plaques in Tissue Sections from APP-PS1 Mice and Humans with Alzheimer's Disease with the Zinc Chelator HQ-O: Practical and Theoretical Considerations

Intraneuronal sortilin aggregation relative to granulovacuolar degeneration, tau pathogenesis and sorfra plaque formation in human hippocampal formation

Inhibiting Mtdna-Sting-nlrp3/il-1β Axis-Mediated Neutrophil Infiltration Protects Neurons in Alzheimer's Disease

Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease

Nanoscale Reorganisation of Synaptic Proteins in Alzheimer's Disease

Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease

In Vivo Target Bio-Imaging of Alzheimer's Disease by Fluorescent Zinc Oxide Nanoclusters.

Label-free Multiphoton Imaging of Β-Amyloid Plaques in Alzheimer’s Disease Mouse Models

Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues

Gram-Negative Bacterial Molecules Associate with Alzheimer Disease Pathology

Recent Research Progress in Fluorescent Probes for Detection of Amyloid- In Vivo

Supplemental Material Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other Driving Chronic Progression of Parkinson ’ s Disease

Pathological Axonal Enlargement in Connection with Amyloidosis, Lysosome Destabilization and Hemorrhage is a Major Defect in the Alzheimer’s Disease

Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration

Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease